Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Jan 2026 for Larimar Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleCarole Ben-Maimon
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Carole Ben-Maimon: trading record in brief
This profile gathers the share dealings of Carole Ben-Maimon in Larimar Therapeutics, Inc. Between 16 September 2022 and 26 January 2026, the trades on record add up to 6 filings.
No open-market sale appears; the market trades are 2 purchases worth €117k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants.
The record was last updated on 27 January 2026 with a share grant in Larimar Therapeutics, Inc. The latest purchase dates back some time: it was published 1,249 days ago, on 18 May 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carole Ben-Maimon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
100,100 shares0Common StockSEC:0001193125-26-024826:0
91,000 shares0Common StockSEC:0001062993-25-001078:0
66,125 shares0Common StockSEC:0001062993-24-001083:0
5,000 shares@ US$3.70514.6% of flowCommon StockSEC:0001062993-23-011546:0
Canonical exit: 15 Aug 2023 (T+90)
205,000 shares0Common StockSEC:0000899243-23-003734:0
31,746 shares@ US$3.1585.4% of flowCommon StockSEC:0001062993-22-019645:0
Canonical exit: 15 Dec 2022 (T+90)
6 of 6 declarations
